Neurological soft signs, clinical symptoms and treatment reactivity in patients suffering from first episode schizophrenia
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
15907940
DOI
10.1016/j.jpsychires.2005.03.008
PII: S0022-3956(05)00041-5
Knihovny.cz E-zdroje
- MeSH
- antipsychotika terapeutické užití MeSH
- chlorpromazin terapeutické užití MeSH
- dospělí MeSH
- lidé MeSH
- mladiství MeSH
- mozek patofyziologie MeSH
- neurologické vyšetření MeSH
- průzkumy a dotazníky MeSH
- schizofrenie * diagnóza farmakoterapie patofyziologie MeSH
- stupeň závažnosti nemoci MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- antipsychotika MeSH
- chlorpromazin MeSH
OBJECTIVE: (a) To investigate the correlation between clinical symptoms and neurological soft signs in patients suffering from their first episode of schizophrenia and (b) to examine the relationship between soft signs and the reactivity of first episode treatment. METHODS: The trial included 92 male patients undergoing a first episode of schizophrenia. The clinical symptoms of the patients were rated on the positive and negative syndrome scale (PANSS). The PANSS scale was used to provide a measure for three syndromes: psychomotor poverty, disorganisation, and reality distortion. Neurological soft signs were assessed with the help of the neurological evaluation scale. RESULTS: The findings corroborated significant positive correlations between soft neurological signs on the one hand and negative symptoms and reduced treatment response on the other. CONCLUSION: Our study of the population of patients with first episode schizophrenia has corroborated the findings of those trials that found a correlation between neurological soft signs and the negative symptomatic dimension of schizophrenia. Another finding of the trial is that neurological soft signs were associated with poorer response to treatment of the first episode of schizophrenia.
Citace poskytuje Crossref.org